| Abbreviation | Explanation |
| ATF | activating transcription factors |
| BP | biological process |
| CaMK | calcium/calmodulin-dependent protein kinase |
| cAMP | cyclic adenosine monophosphate |
| CCN | CYR61 (cysteine-rich angiogenic protein 61), CTGF (connective tissue growth factor), NOV (nephroblastoma overexpressed) |
| CC | cellular components |
| CR | caloric restriction |
| DEGs | differentially expressed genes |
| DENN | differentially expressed in normal and neoplastic cells |
| ERK | extracellular signal-regulated kinases |
| FDR | false discovery rate |
| GO | Gene Ontology |
| HP | hypoxic preconditioning |
| HSPC | pluripotent hematopoietic stem/progenitor cells |
| IL-10 | Interleukin-10 |
| IL-12 | Interleukin-12 |
| IL-17 | Interleukin-17 |
| IL-6 | Interleukin-6 |
| IPO | ischemic postconditioning |
| IRI | ischemia reperfusion injury |
| KEGG | Kyoto Encyclopedia of Genes and Genomes |
| MAPK | mitogen-activated protein kinase |
| MCAO | middle cerebral artery occlusion |
| MF | molecular function |
| MSC | mesenchymal stem cells |
| MT-1 | metallothionein |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| PANTHER | protein analysis through evolutionary relationships |
| ROS | reactive oxidative species |
| TNF | tumor necrosis factor alpha |
| UC-MSC | umbilical cord-derived mesenchymal stem cells |